Nutraplus India Ltd
Nutraplus India is engaged in the Business of Drugs and Pharmaceuticals.
- Market Cap ₹ 7.16 Cr.
- Current Price ₹ 2.10
- High / Low ₹ /
- Stock P/E
- Book Value ₹ -1.53
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 5.00
Pros
Cons
- Company has low interest coverage ratio.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
44.68 | 39.52 | 61.56 | 65.00 | 77.51 | 91.05 | 109.14 | 139.55 | 106.67 | 0.02 | 0.10 | -0.06 | |
38.34 | 32.17 | 51.37 | 61.79 | 65.37 | 92.78 | 99.83 | 126.89 | 142.44 | 0.38 | 3.75 | 0.07 | |
Operating Profit | 6.34 | 7.35 | 10.19 | 3.21 | 12.14 | -1.73 | 9.31 | 12.66 | -35.77 | -0.36 | -3.65 | -0.13 |
OPM % | 14.19% | 18.60% | 16.55% | 4.94% | 15.66% | -1.90% | 8.53% | 9.07% | -33.53% | -1,800.00% | -3,650.00% | |
0.11 | 0.20 | 0.10 | -2.94 | 1.48 | 0.99 | 0.12 | 1.58 | 0.08 | -23.36 | 0.62 | 0.00 | |
Interest | 1.55 | 2.40 | 3.57 | 4.52 | 4.86 | 5.01 | 4.67 | 6.85 | 7.43 | 0.80 | 0.00 | 0.03 |
Depreciation | 0.63 | 1.30 | 1.61 | 1.40 | 1.72 | 2.21 | 3.88 | 4.03 | 4.70 | 0.00 | 0.00 | 0.00 |
Profit before tax | 4.27 | 3.85 | 5.11 | -5.65 | 7.04 | -7.96 | 0.88 | 3.36 | -47.82 | -24.52 | -3.03 | -0.16 |
Tax % | 30.44% | 36.88% | 38.75% | -28.14% | -12.64% | -21.36% | 84.09% | 34.82% | 0.00% | 0.00% | 0.00% | 0.00% |
2.97 | 2.43 | 3.13 | -4.06 | 7.93 | -6.26 | 0.14 | 2.19 | -47.83 | -24.52 | -3.03 | -0.16 | |
EPS in Rs | 2.61 | 1.98 | 2.41 | -1.66 | 2.85 | -1.84 | 0.04 | 0.64 | -14.03 | -7.19 | -0.89 | -0.05 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 7.99% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -160% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 26% |
TTM: | 95% |
Stock Price CAGR | |
---|---|
10 Years: | -15% |
5 Years: | -23% |
3 Years: | 0% |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 5.20 | 5.60 | 5.90 | 11.16 | 12.67 | 17.05 | 17.05 | 17.05 | 17.05 | 17.05 | 17.05 | 17.05 |
Reserves | 7.61 | 10.74 | 14.35 | 30.59 | 45.54 | 50.17 | 50.19 | 52.40 | 4.57 | -19.10 | -22.13 | -22.28 |
14.90 | 21.71 | 31.55 | 40.29 | 72.05 | 65.77 | 73.38 | 74.93 | 75.88 | 1.75 | 1.75 | 1.76 | |
15.87 | 16.39 | 23.44 | 32.02 | 35.34 | 37.27 | 31.21 | 25.32 | 39.37 | 34.99 | 12.28 | 8.72 | |
Total Liabilities | 43.58 | 54.44 | 75.24 | 114.06 | 165.60 | 170.26 | 171.83 | 169.70 | 136.87 | 34.69 | 8.95 | 5.25 |
19.29 | 27.46 | 35.67 | 22.95 | 32.89 | 38.64 | 72.31 | 82.44 | 81.19 | 0.00 | 0.00 | 0.00 | |
CWIP | 0.02 | 0.86 | 1.04 | 13.42 | 37.53 | 48.27 | 21.59 | 17.26 | 12.67 | 0.12 | 0.00 | 0.00 |
Investments | 1.80 | 0.00 | 0.05 | 4.20 | 4.15 | 4.16 | 4.15 | 4.15 | 0.15 | 0.15 | 0.15 | 0.15 |
22.47 | 26.12 | 38.48 | 73.49 | 91.03 | 79.19 | 73.78 | 65.85 | 42.86 | 34.42 | 8.80 | 5.10 | |
Total Assets | 43.58 | 54.44 | 75.24 | 114.06 | 165.60 | 170.26 | 171.83 | 169.70 | 136.87 | 34.69 | 8.95 | 5.25 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
7.57 | 3.50 | 3.98 | -16.49 | -9.61 | 19.66 | 6.69 | 12.36 | 9.07 | -14.25 | -0.15 | 0.02 | |
-10.59 | -8.50 | -10.82 | -5.10 | -34.42 | -18.59 | -10.70 | -9.74 | -2.69 | 93.77 | 0.12 | 0.00 | |
3.12 | 5.10 | 6.80 | 31.53 | 35.54 | -1.91 | 4.00 | -2.66 | -7.57 | -80.25 | 0.00 | -0.03 | |
Net Cash Flow | 0.10 | 0.10 | -0.04 | 9.94 | -8.48 | -0.84 | -0.01 | -0.03 | -1.18 | -0.73 | -0.03 | -0.01 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 98.52 | 97.25 | 87.57 | 75.13 | 119.80 | 104.79 | 83.71 | 42.97 | 9.48 | 19,710.00 | 1,898.00 | -2,676.67 |
Inventory Days | 82.18 | 165.59 | 169.68 | 134.40 | 181.03 | 113.18 | 110.73 | 124.02 | 89.78 | 363.97 | 0.00 | |
Days Payable | 150.75 | 186.82 | 168.01 | 186.44 | 189.62 | 177.37 | 132.71 | 75.89 | 35.11 | 878.67 | ||
Cash Conversion Cycle | 29.96 | 76.02 | 89.25 | 23.09 | 111.21 | 40.60 | 61.73 | 91.10 | 64.15 | 19,710.00 | 1,383.31 | -2,676.67 |
Working Capital Days | 40.44 | 74.63 | 83.66 | 173.68 | 244.26 | 126.16 | 113.47 | 81.84 | 98.27 | 447,855.00 | 0.00 | -22,386.67 |
ROCE % | 25.20% | 18.86% | 19.32% | 3.00% | 10.11% | -2.90% | 4.06% | 8.78% | -33.35% | -0.56% |